150 related articles for article (PubMed ID: 32477006)
1. PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway.
Wu Q; Zhang B; Li B; Cao X; Chen X; Xue Q
Cancer Cell Int; 2020; 20():172. PubMed ID: 32477006
[TBL] [Abstract][Full Text] [Related]
2. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
[TBL] [Abstract][Full Text] [Related]
3. SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.
Feng Y; Guo X; Tang H
Ann Transl Med; 2021 Feb; 9(3):264. PubMed ID: 33708891
[TBL] [Abstract][Full Text] [Related]
4. PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α.
Hou P; Chen F; Yong H; Lin T; Li J; Pan Y; Jiang T; Li M; Chen Y; Song J; Zheng J; Bai J
J Exp Clin Cancer Res; 2019 Jul; 38(1):301. PubMed ID: 31291975
[TBL] [Abstract][Full Text] [Related]
5. PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression.
Chen Y; Ji Y; Liu S; Liu Y; Feng W; Jin L
Cancer Cell Int; 2022 Jan; 22(1):19. PubMed ID: 35016691
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
7. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
Wang L; Qu J; Zhou L; Liao F; Wang J
Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
[TBL] [Abstract][Full Text] [Related]
11. TMEM107 inhibits EMT and invasion of NSCLC through regulating the Hedgehog pathway.
Xu H; Dun S; Gao Y; Ming J; Hui L; Qiu X
Thorac Cancer; 2021 Jan; 12(1):79-89. PubMed ID: 33124203
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis.
Wang Z; Yang MQ; Lei L; Fei LR; Zheng YW; Huang WJ; Li ZH; Liu CC; Xu HT
Cancer Manag Res; 2019; 11():7485-7497. PubMed ID: 31496806
[TBL] [Abstract][Full Text] [Related]
13. Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis.
Liang H; Chen Q; Hu Z; Zhou L; Meng Q; Zhang T; Wang B; Ge Y; Lu S; Ding W; Zhou X; Li X; Lin H; Jiang L; Dong J
Ann Transl Med; 2022 Mar; 10(6):281. PubMed ID: 35434017
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
16. PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing.
Liang X; Chen W; Shi H; Gu X; Li Y; Qi Y; Xu K; Zhao A; Liu J
Cell Death Dis; 2018 May; 9(5):569. PubMed ID: 29752441
[TBL] [Abstract][Full Text] [Related]
17. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
Li N; Gao WJ; Liu NS
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
Liang X; Shi H; Yang L; Qiu C; Lin S; Qi Y; Li J; Zhao A; Liu J
Br J Cancer; 2017 Mar; 116(7):903-911. PubMed ID: 28222070
[TBL] [Abstract][Full Text] [Related]
20. Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer.
Xia HW; Zhang ZQ; Yuan J; Niu QL
Life Sci; 2021 Jan; 265():118768. PubMed ID: 33217443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
